Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Eliminate skin blemishes 21
Depending on your protocol, peptides can be administered through subcutaneous injections, nasal sprays, or capsules and many patients start noticing results within a few weeks
Due to their diverse structures, the pharmacokinetic profiles vary, and a prolonged half-life may be associated with an increased risk of adverse events
We have taken these comments into consideration in our final determination for pass-through status for the nominated devices included in the CY 2026 OPPS/ASC proposed rule
Staying hydrated is important, particularly during hot weather or when exercising